Overview
- Researchers led by Francesco Rubino validated the two‑step waist‑plus‑organ framework after Wednesday's Nature study of 844,108 adults in China, Spain, the U.K. and the U.S. showed it outperformed BMI alone.
- The study found BMI missed obesity-level excess fat in about 8.6% of people and incorrectly classified about 3.1% as having obesity when their weight did not reflect immediate organ risk.
- People classified with clinical obesity had roughly 69% higher mortality in the study while those with preclinical obesity had about 19% higher mortality, and 77% to 91% of preclinical cases did not progress to clinical obesity over 10 years.
- If adopted, the two‑step approach could reshape who is labeled obese and who becomes eligible for treatments such as GLP‑1 drugs, but experts say practical steps are needed on cutoffs, ethnicity‑specific thresholds, workflow trials and clinician training before routine use.
- The change responds to long‑standing limits of BMI, a 19th‑century height‑weight index that cannot separate fat from muscle or show fat distribution, and could materially alter prevalence estimates and health‑system costs if rolled out.